PRAME TCR Engineered NK Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PRAME TCR Engineered NK Cells, covering 2026-04-16 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel) [Phase 1]